In addition to hereditary breast and ovarian cancer (HBOC), FANCJ mutations are found in melanoma, prostate, and hereditary colon cancer, providing evidence that FANCJ mutations may be a risk factor in multiple types of cancer (9-11). Indeed, FANCJ, BRCA1, and BRCA2 are bi-allelically mutated in Fanconi anemia (FA), a bone marrow failure disease that also predisposes to cancers such as leukemia (12).Consistent with its roles as an ATPase, DNA helicase, and translocase, FANCJ contains a highly conserved helicase homology domain with seven conserved motifs including Walker A and Walker B boxes, as well as an iron-sulfur (Fe-S) cluster that are all essential for its catalytic activity (see Figure1A). The DNA-dependent ATPase function of FANCJ catalytically unwinds a range of duplex DNA substrates as well as secondary DNA on May 10, 2021.